ICMR Licenses SHetA2 for Early Cervical Cancer Trials
The Indian Council of Medical Research has licensed the experimental drug SHetA2 to Emcure Pharmaceuticals for manufacturing, regulatory development and human clinical trials. Developed through research at the University of Oklahoma and…
